CAD 0.57
(0.0%)
Breakdown | 2023 | 2022 | 2021 | 2020 |
---|---|---|---|---|
Operating Cash Flow | -2.42 Million | -407.03 | -11.66 Thousand | - |
Net Income | -2.31 Million | -490.34 | -14.55 Thousand | -5700.00 |
Depreciation & Amortization | - | - | - | - |
Deferred income taxes | - | - | - | - |
Stock-based compensation | - | 9.99 | - | - |
Change in working capital | 87.59 Thousand | -13.41 | 2887.00 | 5700.00 |
Other non-cash items | 92.49 Thousand | 86.73 | 2.89 | 5.70 |
Investing Cash Flow | -206 Thousand | 149.01 | - | - |
Investments in PPE | -206 Thousand | - | - | - |
Acquisitions | - | 149.01 | - | - |
Investment purchases | - | - | - | - |
Sales/Maturities of investments | - | - | - | - |
Other Investing Activities | - | - | - | - |
Financing Cash Flow | 3.74 Million | 326.75 | 41.68 Thousand | - |
Debt repayment | -120 Thousand | - | -41.68 Thousand | - |
Dividends payments | - | - | - | - |
Common Stock Repurchased | - | - | - | - |
Common Stock Issuance | 2.29 Million | - | - | - |
Other Financing Activities | -478.26 Thousand | 326.75 | 41.69 | - |
Accounts receivables | -20.65 | -0.37 | - | - |
Accounts payables | - | - | - | - |
Inventory | - | - | - | - |
Other working capital | -97.00 | -13.04 | - | - |
Cash at beginning of period | 92.26 Thousand | 31.35 | 1329.00 | 1329.00 |
Cash at end of period | 1.2 Million | 100.08 | 31.35 Thousand | 1329.00 |
Capital Expenditure | -206 Thousand | - | - | - |
Effect of forex changes on cash | - | - | - | - |
Net cash flow / Change in cash | 1.11 Million | 68.73 | 30.02 Thousand | - |
Free Cash Flow | -2.62 Million | -407.03 | -11.66 Thousand | - |
Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | -1.35 Million | -18.92 Million | -1.16 Million | -2.31 Million | -516.21 Thousand | -741.25 Thousand |
Depreciation & Amortization | 11.87 Thousand | 1.82 | - | - | - | - |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | 181.49 Thousand | 2167.83 | - | - | - | - |
Change in working capital | -1.35 Million | 1.85 Million | 8231.00 | 87.59 Thousand | -28.85 Thousand | 168.87 Thousand |
Other non-cash items | -2025.99 | 14.71 Thousand | 172.44 | 92.49 Thousand | 36.36 Thousand | 110.02 |
Investing Cash Flow | -155.36 Thousand | -109.34 Thousand | -11 Thousand | -206 Thousand | - | - |
Investments in PPE | -155.36 Thousand | -109.34 Thousand | -11 Thousand | -206 Thousand | - | - |
Acquisitions | - | - | - | - | - | - |
Investment purchases | - | - | - | - | - | - |
Sales/Maturities of investments | - | - | - | - | - | - |
Other Investing Activities | - | - | - | - | - | - |
Financing Cash Flow | 2.58 Million | 4.26 Million | - | 3.74 Million | 1.89 Million | - |
Debt repayment | - | - | - | -120 Thousand | - | - |
Dividends payments | - | - | - | - | - | - |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | - | - | - | 2.29 Million | 2.29 Million | - |
Other Financing Activities | 2588.64 | 4262.25 | - | -478.26 Thousand | -394 Thousand | - |
Accounts receivables | 3.28 | 21.02 | -7.90 | -20.65 | -15.16 | -3.30 |
Accounts payables | - | - | - | - | - | - |
Inventory | - | - | - | - | - | - |
Other working capital | -0.44 | -0.43 | 16.30 | -97.00 | -78.54 | 62.16 |
Cash at beginning of period | 2.34 Million | 211.75 Thousand | 1.2 Million | 92.26 Thousand | 109.68 Thousand | 682.05 Thousand |
Cash at end of period | 1.59 Million | 2.34 Million | 211.75 Thousand | 1.2 Million | 1.2 Million | 109.68 Thousand |
Capital Expenditure | -155.36 Thousand | -109.34 Thousand | -11 Thousand | -206 Thousand | - | - |
Effect of forex changes on cash | - | - | - | - | - | - |
Net cash flow / Change in cash | -747.66 Thousand | 2.13 Million | -996.08 Thousand | 1.11 Million | 1.09 Million | -572.37 Thousand |
Free Cash Flow | -3.33 Million | -2.12 Million | -996.08 Thousand | -2.62 Million | -798.85 Thousand | -572.37 Thousand |
002527
BMOB3
OLECTRA
REGENCERAM
002947
DANM